Rekah Pharmaceutical Industry Ltd (REKA) — Financial Flexibility Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of ILA7.37 Million (operating CF ILA5.27 Million minus capex ILA2.10 Million) represents 0% of total liabilities (ILA279.47 Million). Also explore REKA net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Rekah Pharmaceutical Industry Ltd across 20 annual periods. Check Rekah Pharmaceutical Industry Ltd (REKA) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Rekah Pharmaceutical Industry Ltd (2004–2025)
Year-by-year free cash flow to debt coverage for Rekah Pharmaceutical Industry Ltd. For the full company profile including market capitalisation, see REKA company net worth.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | ILA19.98 Million | ILA12.95 Million | ILA279.47 Million | ▼ -42.1% |
| 2024 | 0.12x | ILA35.24 Million | ILA26.54 Million | ILA285.24 Million | ▲ +2.1% |
| 2023 | 0.12x | ILA39.84 Million | ILA28.35 Million | ILA329.14 Million | ▼ -25.4% |
| 2022 | 0.16x | ILA46.48 Million | ILA39.00 Million | ILA286.34 Million | ▲ +21.9% |
| 2021 | 0.13x | ILA35.16 Million | ILA21.17 Million | ILA264.02 Million | ▲ +12.4% |
| 2020 | 0.12x | ILA30.12 Million | ILA11.28 Million | ILA254.10 Million | ▼ -68.3% |
| 2019 | 0.37x | ILA79.31 Million | ILA33.91 Million | ILA211.89 Million | ▲ +72.5% |
| 2018 | 0.22x | ILA32.46 Million | ILA17.28 Million | ILA149.62 Million | ▼ -19.0% |
| 2017 | 0.27x | ILA40.27 Million | ILA23.80 Million | ILA150.33 Million | ▲ +60.2% |
| 2016 | 0.17x | ILA36.27 Million | ILA22.82 Million | ILA216.86 Million | ▲ +76.6% |
| 2015 | 0.09x | ILA18.95 Million | ILA5.81 Million | ILA200.17 Million | ▲ +7.1% |
| 2014 | 0.09x | ILA20.60 Million | ILA1.33 Million | ILA233.05 Million | ▲ +22.9% |
| 2013 | 0.07x | ILA16.09 Million | ILA11.71 Million | ILA223.65 Million | ▼ -32.0% |
| 2012 | 0.11x | ILA24.00 Million | ILA14.18 Million | ILA226.90 Million | ▲ +62.4% |
| 2010 | 0.07x | ILA14.61 Million | ILA6.73 Million | ILA224.18 Million | ▼ -60.5% |
| 2009 | 0.17x | ILA35.36 Million | ILA26.03 Million | ILA214.25 Million | ▲ +121.2% |
| 2008 | 0.07x | ILA17.30 Million | ILA6.57 Million | ILA231.87 Million | ▼ -1.6% |
| 2007 | 0.08x | ILA17.73 Million | ILA12.45 Million | ILA233.86 Million | ▲ +38.9% |
| 2005 | 0.05x | ILA11.36 Million | ILA4.27 Million | ILA208.15 Million | ▼ -63.0% |
| 2004 | 0.15x | ILA22.57 Million | ILA17.87 Million | ILA153.18 Million | — |